Patents Examined by Thomas J Visone
-
Patent number: 8986678Abstract: The present invention relates to methods of in vitro preparation of a parental cell bank (PCB) from foetal tissue consisting of foetal epiphyseal tissue, foetal Achilles tendon tissue and foetal skin tissue, using a rapid mechanical primary cell culture selection of cell type to be used in methods for wound and tissue repair.Type: GrantFiled: July 10, 2012Date of Patent: March 24, 2015Assignee: Centre Hospitalier Universitaire VaudoisInventor: Lee Ann Laurent-Applegate
-
Patent number: 8986991Abstract: A system and method of adapting host cells to suspension cell culture and suspension cell lines ATCC PTA-12593 and ATCC PTA-12461 produced thereby are disclosed. The method includes the serial replating of substantially undiluted culture cells onto a surface area until cell clumps are visualized and then, upon cell clumping, moving the cells into a suspension culture system.Type: GrantFiled: July 1, 2013Date of Patent: March 24, 2015Assignee: Expression Therapeutics, LLCInventors: Gabriela D. C. Denning, Richard E Gautney
-
Patent number: 8961963Abstract: Disclosed is a pharmaceutical natural composition containing both statin compounds (mevinolin and mevinolinic acid) serving as cholesterol biosynthesis inhibitors and coenzyme Q (ubiquinone-10: CoQ10 and ubiquinone-9: CoQ9) compounds which are substances that inhibit factors causing complications such as myalgia involved in long-term use of the statin, prepared using Monascus sp. and natural medicinal substances such as ginseng, mushrooms and cereals.Type: GrantFiled: December 28, 2009Date of Patent: February 24, 2015Assignee: Sungshin Women's University Industry-Academic Cooperation FoundationInventor: Young-Hee Pyo
-
Patent number: 8889416Abstract: Provided herein are devices and methods for the micro-isolation of biological cellular material. A micro-isolation apparatus described can comprise a photomask that protects regions of interest against DNA-destroying illumination. The micro-isolation apparatus can further comprise photosensitive material defining access wells following illumination and subsequent developing of the photosensitive material. The micro-isolation apparatus can further comprise a chambered microfluidic device comprising channels providing access to wells defined in photosensitive material. The micro-isolation apparatus can comprise a chambered microfluidic device without access wells defined in photosensitive material where valves control the flow of gases or liquids through the channels of the microfluidic device.Type: GrantFiled: January 20, 2011Date of Patent: November 18, 2014Assignees: California Institute of Technology, University of Southern CaliforniaInventors: Emil P. Kartalov, Darryl Shibata, Clive Taylor, Lawrence A. Wade
-
Patent number: 8883470Abstract: A high yield method for fermenting carbohydrate to ethanol, comprising a) treating carbohydrate with a composition containing 10-90 wt % of an aldehyde selected from the group consisting of an formaldehyde, para-formaldehyde, glutaraldehyde and mixtures thereof, 1-50 wt % of a surfactant having an I JLB from 4 to 18, 0-20 wt % of an antimicrobial terpene, or essential oils, 1-50 wt % of organic acids selected from C1-24 fatty acids, their salts, and glyceride esters thereof, and 1-50 wt % water, b) fermenting said carbohydrate in the presence of yeast in a fermentation broth, and c) isolating ethanol in a higher yield than would be obtained without step a).Type: GrantFiled: November 23, 2010Date of Patent: November 11, 2014Assignee: Anitox CorporationInventors: Julio Pimentel, James D. Wilson
-
Patent number: 8877493Abstract: The present invention provides a culture substrate which enables maintenance culture of human pluripotent stem cells in a pluripotent state under a feeder-free culture environment, and a culture method of human pluripotent stem cells using the culture substrate. By seeding human pluripotent stem cells dissociated into single cells at a cell density of 4×104 to 10×104 cells/cm2 onto a culture substrate coated with human laminin ?5?1?1 E8 fragment or human laminin ?3?3?2 E8 fragment preferably at a concentration of 0.5 to 25 ?g/cm2, the human pluripotent stem cells can be rapidly expanded in a pluripotent state.Type: GrantFiled: October 7, 2010Date of Patent: November 4, 2014Assignees: Osaka University, Kyoto UniversityInventors: Kiyotoshi Sekiguchi, Sugiko Futaki, Yukimasa Taniguchi, Maria Hayashi, Norio Nakatsuji, Takamichi Miyazaki, Eihachiro Kawase, Hirofumi Suemori
-
Patent number: 8852880Abstract: Method of in vitro measurement of the presence of factors that are able to neutralize asparaginase activity in a sample of blood, plasma, serum or derived medium that may contain asparaginase neutralizing factors, obtained from a patient, comprising mixing of said sample with asparaginase, incubation of said mixture, then measurement of the residual asparaginase activity in the mixture and determination or quantification of the presence of said neutralizing factors. Method for predicting the efficacy of a treatment with asparaginase.Type: GrantFiled: November 6, 2009Date of Patent: October 7, 2014Assignee: Erytech PharmaInventor: Yann Godfrin
-
Patent number: 8841125Abstract: Disclosed is a novel cell mass derived from a cancer tissue, which can reflect the in vivo behavior of a cancer cell correctly. Also disclosed is a process for preparing the cell mass. Specifically disclosed is a cell mass derived from a cancer tissue, which is an separated product that is isolated from a cancer tissue obtained from an individual as a mass containing at least three cancer cells or a cultured product of the separated product and which can retain a proliferation ability in vitro. The cell mass derived from a cancer tissue is produced by, for example, a preparation process comprising the steps of: treating a pulverized product of a cancer tissue removed from a living body with an enzyme; and selecting and collecting a mass containing at least three cancer cells among from an enzymatic treatment product.Type: GrantFiled: March 31, 2014Date of Patent: September 23, 2014Assignees: Renaissance Energy Investment Co., Ltd., Osaka Prefectural Hospital OrganizationInventors: Masahiro Inoue, Masayuki Ohue
-
Patent number: 8795957Abstract: The present invention provides a blood collection container capable of allowing blood to coagulate in a short time and preventing blood from coagulating with bubbles contained therein and thus preventing formation of bubbly clots when used to collect blood therein. A blood collection container 1 stores a blood coagulation promoting agent 4 for promoting blood coagulation and an antifoaming agent 5, which is a polyoxyalkylene or a derivative thereof. The amount of the antifoaming agent 5 is 2.0×10?3 to 0.2 mg per mL of blood to be collected in the blood collection container 1.Type: GrantFiled: February 23, 2011Date of Patent: August 5, 2014Assignee: Sekisui Medical Co., Ltd.Inventors: Tomonori Inoue, Yuuji Setoguchi, Ryusuke Okamoto, Katsuya Togawa
-
Patent number: 8796020Abstract: The present application discloses a method of obtaining multi-lineage stem cells or progenitor cells by allowing a sample of cells to settle in a container; transferring supernatant from the container to another container; and eventually isolating a colony from the supernatant after several transfer/settle processes and expanding further, and optionally freezing the cells thus obtained.Type: GrantFiled: December 30, 2011Date of Patent: August 5, 2014Assignee: Inha-Industry Partnership InstituteInventor: Sun Uk Song
-
Patent number: 8715974Abstract: It is intended to provide a novel NAD+-independent myo-inositol 2-dehydrogenase which converts myo-inositol into scyllo-inosose in the absence of NAD+; a novel enzyme scyllo-inositol dehydrogenase which stereospecifically reduces scyllo-inosose into scyllo-inositol in the presence of NADH or NADPH; and a novel microorganism which belongs to the genus Acetobacter or Burkholderia and can convert myo-inositol into scyllo-inositol. By using these enzymes or the microorganism, scyllo-inositol is produced. Furthermore, scyllo-inositol is purified by adding boric acid and a metal salt to a liquid mixture containing scyllo-inositol and a neutral saccharide other than scyllo-inositol to form a scyllo-inositol/boric acid complex, separating the complex from the liquid mixture, dissolving the thus separated complex in an acid to give an acidic solution or an acidic suspension and then purifying scyllo-inositol from the acidic solution or the acidic suspension.Type: GrantFiled: March 8, 2013Date of Patent: May 6, 2014Assignee: Hokko Chemical Industry Co., Ltd.Inventors: Masanori Yamaguchi, Yuichi Kita, Tetsuya Mori, Kenji Kanbe, Akihiro Tomoda, Atsushi Takahashi, Wakako Ichikawa
-
Patent number: 8709750Abstract: A device and method for processing an algae medium containing algae microorganisms to produce algal oil and by-products thereof. The method comprises pumping the algae medium through a flow-through hydrodynamic cavitation device, generating localized zones of reduced fluid pressure, creating cavitational features in the algae medium, collapsing those cavitation features, and disintegrating cell walls and intracellular organelles to produce algal oil and by-products.Type: GrantFiled: December 14, 2009Date of Patent: April 29, 2014Assignee: Cavitation Technologies, Inc.Inventors: Roman Gordon, Igor Gorodnitsky, Varvara Grichko
-
Patent number: 8652841Abstract: In a culture method of the present invention, by culturing bone marrow stromal cells or mesenchymal stem cells under a pseudo micro-gravity environment generated by multi-axis rotation, bone marrow stromal cells or mesenchymal stem cells having an average cell size smaller than that before the culture are obtained. The bone marrow stromal cells or mesenchymal stem cells thus cultured are suitable as graft cells for a central nerve diseases therapy.Type: GrantFiled: April 12, 2010Date of Patent: February 18, 2014Assignees: Mitsubishi Heavy Industries, Ltd.Inventors: Toshimasa Ochiai, Louis Yuge, Yumi Kawahara
-
Patent number: 8628767Abstract: A process for inhibiting a mammalian cancerous cell or virally infected cell includes providing a Trichomonas vaginalis purine nucleoside phosphorylase enzyme or a tail mutant purine nucleoside phosphorylase enzyme in proximity to the mammalian cancerous cell or the virally infected cell and exposing the enzyme to a purine nucleoside phosphorylase enzyme cleavable substrate to yield a cytotoxic purine analog. The process includes introducing to the cell a vector containing the phosphorylase enzyme, or a DNA sequence coding for the same and delivering to the cell an effective amount of the substrate such as 9-(?-D-arabinofuranosyl)-2-fluoroadenine (F-araA).Type: GrantFiled: August 17, 2009Date of Patent: January 14, 2014Assignees: The UAB Research Foundation, Southern Research InstituteInventors: William B. Parker, Eric J. Sorscher
-
Patent number: 8617892Abstract: A hydrogel tissue engineering scaffold having microbubbles dispersed therein is disclosed. Also, a system for cell culturing including a controller and actuator to apply dynamic deformational loading to a hydrogel is disclosed. Also disclosed are methods for producing hydrogels with microbubbles and for culturing cells using hydrogels with microbubbles.Type: GrantFiled: August 31, 2010Date of Patent: December 31, 2013Assignee: The Trustees of Columbia University in the City of New YorkInventors: Mark A. Borden, Eric G. Lima, Clark T. Hung, Shashank Ramesh Sirsi
-
Patent number: 8574899Abstract: The subject matter of this invention is a novel method to augment the process of obtaining populations of placental hematopoietic stem and progenitor cells for use in medical practices. A method of augmentation of stem cells collection from placenta is claimed comprising the steps of (a) infusing placental vessels cell preservation compound and a with a composition containing blockers of cell adhesion receptors, (b) incubating said placenta for a sufficient period of time, (c) placing placenta in a containment with sufficient intensity of electromagnetic or ultrasound field for a sufficient period of time; (d) eluting cell suspension from placental vessels, (e) collecting cell suspension and harvesting cells. Invention further claims a method of treatment a disease by means of administering therapeutic composition containing said placental-derived hematopoietic stem cells.Type: GrantFiled: December 12, 2011Date of Patent: November 5, 2013Inventors: Vladimir B Serikov, Frans A Kuypers
-
Patent number: 8501458Abstract: An isolated fungus is described. The isolated fungus produces at least one compound selected from the group consisting of 1,8-cineole, 1-methyl-1,4-cyclohexadiene, and (+)-?-methylene-?-fenchocamphorone. A method for producing at least one compound selected from the group consisting of 1,8-cineole, 1-methyl-1,4-cyclohexadiene, and (+)-?-methylene-?-fenchocamphorone is also described. The method includes culturing a fungus on or within a culturing media in a container under conditions sufficient for producing the at least one compound.Type: GrantFiled: May 18, 2011Date of Patent: August 6, 2013Inventors: Gary A. Strobel, Angela R. Tomsheck
-
Patent number: 8409833Abstract: It is intended to provide a novel NAD+-independent myo-inositol 2-dehydrogenase which converts myo-inositol into scyllo-inosose in the absence of NAD+; a novel enzyme scyllo-inositol dehydrogenase which stereospecifically reduces scyllo-inosose into scyllo-inositol in the presence of NADH or NADPH; and a novel microorganism which belongs to the genus Acetobacter or Burkholderia and can convert myo-inositol into scyllo-inositol. By using these enzymes or the microorganism, scyllo-inositol is produced. Furthermore, scyllo-inositol is purified by adding boric acid and a metal salt to a liquid mixture containing scyllo-inositol and a neutral saccharide other than scyllo-inositol to form a scyllo-inositol/boric acid complex, separating the complex from the liquid mixture, dissolving the thus separated complex in an acid to give an acidic solution or an acidic suspension and then purifying scyllo-inositol from the acidic solution or the acidic suspension.Type: GrantFiled: February 25, 2010Date of Patent: April 2, 2013Assignee: Hokko Chemical Industry Co., Ltd.Inventors: Masanori Yamaguchi, Yuichi Kita, Tetsuya Mori, Kenji Kanbe, Akihiro Tomoda, Atsushi Takahashi, Wakako Ichikawa